Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orthomyxoviridae Infections | 5 | 2025 | 42 | 3.590 |
Why?
|
| Influenza A virus | 4 | 2025 | 40 | 2.950 |
Why?
|
| Influenza, Human | 4 | 2023 | 95 | 2.260 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2022 | 43 | 1.660 |
Why?
|
| Interferon-gamma | 2 | 2025 | 109 | 1.530 |
Why?
|
| Lung Injury | 2 | 2023 | 34 | 1.480 |
Why?
|
| Communicable Diseases | 2 | 2023 | 21 | 1.470 |
Why?
|
| Cigarette Smoking | 2 | 2025 | 85 | 1.460 |
Why?
|
| Lung | 6 | 2025 | 385 | 1.400 |
Why?
|
| Bacillus anthracis | 3 | 2023 | 154 | 0.950 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2025 | 8 | 0.910 |
Why?
|
| Anthrax | 3 | 2023 | 92 | 0.890 |
Why?
|
| Pneumonia | 1 | 2022 | 89 | 0.690 |
Why?
|
| Smoke | 1 | 2021 | 37 | 0.670 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 214 | 0.630 |
Why?
|
| Interferon Type I | 1 | 2020 | 56 | 0.630 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 285 | 0.600 |
Why?
|
| Antiviral Agents | 1 | 2020 | 114 | 0.600 |
Why?
|
| Immunotherapy | 1 | 2020 | 171 | 0.560 |
Why?
|
| Tobacco Products | 1 | 2021 | 209 | 0.530 |
Why?
|
| Immunity, Innate | 2 | 2025 | 233 | 0.450 |
Why?
|
| Spores, Bacterial | 3 | 2023 | 50 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 1672 | 0.400 |
Why?
|
| Animals | 5 | 2025 | 10756 | 0.350 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 93 | 0.310 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2009 | 11 | 0.310 |
Why?
|
| Mice | 3 | 2025 | 4845 | 0.310 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 1522 | 0.270 |
Why?
|
| Humans | 8 | 2025 | 29078 | 0.250 |
Why?
|
| Cytokines | 2 | 2023 | 456 | 0.230 |
Why?
|
| Chemokines | 2 | 2018 | 74 | 0.210 |
Why?
|
| Epithelial Cells | 2 | 2023 | 267 | 0.200 |
Why?
|
| Mice, Knockout | 1 | 2025 | 876 | 0.180 |
Why?
|
| Interferon-beta | 1 | 2022 | 40 | 0.180 |
Why?
|
| Tobacco | 1 | 2022 | 87 | 0.170 |
Why?
|
| Immune Evasion | 1 | 2020 | 9 | 0.160 |
Why?
|
| Macrophages | 1 | 2023 | 306 | 0.160 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2018 | 15 | 0.140 |
Why?
|
| Male | 2 | 2025 | 14049 | 0.130 |
Why?
|
| Inflammation | 1 | 2022 | 669 | 0.130 |
Why?
|
| Time Factors | 1 | 2021 | 1619 | 0.130 |
Why?
|
| Female | 2 | 2025 | 15740 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2016 | 103 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 477 | 0.120 |
Why?
|
| Movement | 1 | 2016 | 100 | 0.120 |
Why?
|
| Antigens, Bacterial | 1 | 2016 | 166 | 0.110 |
Why?
|
| Organ Culture Techniques | 2 | 2016 | 56 | 0.110 |
Why?
|
| Bacterial Toxins | 1 | 2016 | 276 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2009 | 28 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 26 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2009 | 1482 | 0.050 |
Why?
|
| Platelet Factor 4 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Chemokine CCL20 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Chemokine CXCL5 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2018 | 45 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 37 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 247 | 0.030 |
Why?
|
| Monocytes | 1 | 2018 | 135 | 0.030 |
Why?
|
| Neutrophils | 1 | 2018 | 185 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 33 | 0.030 |
Why?
|
| Blood | 1 | 2016 | 34 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2016 | 135 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 701 | 0.030 |
Why?
|